SC 13D

Company

Zivo Bioscience, Inc.

Filed

January 22, 2024

Accession Number

0001654954-24-000795

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →